YO39523 / IMagyn050/ GOG 3016/ ENGOT ov39

A Phase III, multicenter, randomized study of Atezolizumab Versus Placebo administered in combination with paclitaxel, carboplatin, and bevacizumab for patients with newly‑diagnosed stage III or stage IV ovarian, fallopian tube, or primary peritoneal cancer.